During the past decade, HeartCare Midwest conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 13 clinical trials were completed, i.e. on average, 216.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HeartCare Midwest" #1 sponsor was "Abbott Medical Devices" with 5 trials, followed by "Actelion" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "United Therapeutics" with 2 trials sponsored and "Abbott" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HeartCare Midwest" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Baim Institute for Clinical Research" with 1 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "Daiichi Sankyo, Inc." with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "HeartCare Midwest" are "Heart Failure" (4 trials), "Pulmonary Arterial Hypertension" (3 trials), "Congestive Heart Failure" (2 trials), "Heart Failure, Congestive" (2 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "HeartCare Midwest" in a lesser frequency.

Most popular intervention types in "HeartCare Midwest" are "Drug" (17 trials), "Device" (8 trials), "Procedure" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Apixaban" (2 trials), "Aspirin" (1 trials), "CRT-D System" (1 trials) and "Canagliflozin 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "HeartCare Midwest" are 25 trials for "All" genders.

Currently, there are NaN active trials in "HeartCare Midwest". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 18 completed trials in HeartCare Midwest, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in HeartCare Midwest, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".